A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States

NCT07122193 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuromuscular Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Acetylcholine Release Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Cholinergic Agents
Neurotransmitter Agents
incobotulinumtoxinA
Botulinum Toxins, Type A

Interventions

DRUG: NT 201
DRUG: NT 201 Placebo

Sponsor

Merz North America, Inc.